Performance of new anticoagulants for thromboprophylaxis in patients undergoing hip and knee replacement surgery.

about

Performance of new anticoagulants for thromboprophylaxis in patients undergoing hip and knee replacement surgery.

Item

http://www.wikidata.org/entity/Q38057678

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Performance of new anticoagula ...... and knee replacement surgery.

@en

type

Item

label

Performance of new anticoagula ...... and knee replacement surgery.

@en

prefLabel

Performance of new anticoagula ...... and knee replacement surgery.

@en

P1476

Performance of new anticoagula ...... and knee replacement surgery.

@en

P2093

Charles E Mahan

http://www.w3.org/2001/XMLSchema#string

Scott Kaatz

http://www.w3.org/2001/XMLSchema#string

P2860

Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE start).

Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery.

Apixaban or enoxaparin for thromboprophylaxis after knee replacement.

Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial.

Apixaban versus enoxaparin for thromboprophylaxis after hip replacement.

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial.

Clinical safety, tolerability, pharmacokinetics, and pharmacodynamics of the novel factor Xa inhibitor edoxaban in healthy volunteers.

P304

1036-1048

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PHAR.1133

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23124723

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation